A basis for human QT interval prolongation and arrhythmia risk in type 2 diabetes?

Jules C Hancox

doi:10.1113/EP086618

A basis for human QT interval prolongation and arrhythmia risk in type 2 diabetes?

Jules C Hancox

School of Physiology, Pharmacology & Neuroscience

Research output: Contribution to journal › Comment/debate (Academic Journal)

1 Citation (Scopus)

188 Downloads (Pure)

Abstract

[no abstract]

Original language	English
Pages (from-to)	1395-1396
Number of pages	2
Journal	Experimental Physiology
Volume	102
Issue number	11
Early online date	2 Sep 2017
DOIs	https://doi.org/10.1113/EP086618
Publication status	Published - 2 Sep 2017

Keywords

diabetes
hERG
NCX
QT interval
QT prolongation

Access to Document

10.1113/EP086618

Full-text PDF (accepted author manuscript)
This is the author accepted manuscript (AAM). The final published version (version of record) is available online via Wiley at http://onlinelibrary.wiley.com/doi/10.1113/EP086618/abstract . Please refer to any applicable terms of use of the publisher.
Accepted author manuscript, 114 KB

Cite this

@article{e2ce0bfd1ffd464793ba4c7a2ee16296,

title = "A basis for human QT interval prolongation and arrhythmia risk in type 2 diabetes?",

abstract = "[no abstract]",

keywords = "diabetes, hERG, NCX, QT interval, QT prolongation",

author = "Hancox, {Jules C}",

year = "2017",

month = sep,

day = "2",

doi = "10.1113/EP086618",

language = "English",

volume = "102",

pages = "1395--1396",

journal = "Experimental Physiology",

issn = "0958-0670",